April 2018 FDA Recall Drug by Epic Products, Llc
D-0288-2019 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Epic Products, Llc on April 16, 2018 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0288-2019

Reason for Recall
Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.
Initiated
04-16-2018
Reported
11-21-2018
Quantity
a) 106,329 cards; b) 109,725 bottles; c) 28,644 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide in the USA
Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.

Batch or Lot Expiration Information

Lot# All lots